Diagnostic Identifies Squamous Lung Cancer With 96% Sensitivity
A new study shows for the first time that a microRNA-based diagnostic test can objectively identify squamous lung cancer with 96% sensitivity.
Read MoreMonth: March 2009
New SVP and Chief Medical Officer Named at Quest
Quest Diagnostics Inc, announces that Jon R. Cohen, MD, Senior Advisor to New York Governor David A. Paterson, will join the company as Senior Vice President and Chief Medical Officer on March 30, 2009.
Read MoreStreck Introduces Whole Blood Control for Flow Cytometry
Streck today announces the introduction of CD4 Count, a new whole blood quality control for verifying the accuracy of the BD FACSCount flow cytometer.
Read MoreAMDL Collaborates with Mayo Clinic to Advance Cancer Test
AMDL Inc announces that it has entered into a collaborative agreement with Mayo Clinic to conduct a clinical study for the validation of AMDL’s next generation version of its US FDA-approved DR-70 (FDP) cancer test.
Read MoreNew Technique Increases Accuracy of Staging Bladder Cancer Tumors
Pathologists this week reported encouraging results from a new technique to increase the accuracy of staging bladder cancer tumors, performed by pathologists before surgery.
Read More